reported that RAB8A promotes the proliferation, migration, and invasion of breast cancer cells through inhibiting Tyrosine Kinase Receptor B (TRKB), a specific receptor for Brain-Derived Neurotrophic Factor (BDNF) [40]. Here, NTRK2 is linked to breast carcinoma.